By Rédaction Africa Links 24 with AHIT
Published on 2024-01-23 14:41:41
Dawa Mkononi is a B2B pharmaceutical company based in Tanzania that is dedicated to utilizing innovation to enhance the supply chain and has recently secured funding to further its mission of improving healthcare access in East Africa. The company’s operations are primarily focused on serving pharmacies, health facilities, and other registered B2B clients, using data-driven approaches to improve medicine distribution and availability in health facilities.
The funding for Dawa Mkononi comes from various financial backers, including the Sanofi Global Health Unit Impact Fund, Pontem Ventures, Warioba Ventures, Villgro Africa, Axian Group, as well as several regional venture capitalists. This financial support will enable the company to advance its mission of providing universal access to essential medications.
Joseph Paul, the CEO and co-founder of Dawa Mkononi, expressed gratitude for the investors’ support, emphasizing the significance of their backing in expanding the company’s footprint and enhancing healthcare access across Tanzania. The company’s mobile application, “Dawa Mkononi,” which translates to “Medicine at your Palms,” directly addresses the pharmaceutical supply chain by enabling pharmacies, clinics, and hospitals to efficiently order medicines, while also providing fintech features for a seamless payment system.
Through its innovative approach, Dawa Mkononi not only conserves resources but also prevents price volatility and the distribution of counterfeit drugs. With a current reach of over 1,000 healthcare enterprises in Dar es Salaam alone, the company’s impact extends beyond large cities. The recent financial support will enable Dawa Mkononi to expand its reach to remote areas, ensuring that essential medications are accessible to all. The company serves as an example of how technology can address healthcare gaps and facilitate universal access to vital medical supplies in underserved regions.
Overall, Dawa Mkononi’s innovative and data-driven approach, combined with the recent financial support, positions the company to continue making significant strides in improving healthcare access and medicine distribution across East Africa.
Read the original article on Africa Health News
